Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Korro Bio
Biotech
Korro Bio merges with off-pitch Frequency, tacks on $117M
Korro Bio is jumping onto Wall Street less than four years after launching from the port of Atlas Venture.
Max Bayer
Jul 14, 2023 9:50am
Billy Dunn departs FDA—Chutes & Ladders
Mar 3, 2023 9:30am
Korro Bio rings in new year with $116M for OPERA RNA editing
Jan 5, 2022 7:30am
Proxy brawler Denner joins board at Ironwood—Chutes & Ladders
Nov 13, 2020 10:20am
Bermingham's Korro Bio lands ex-Corvidia executive as CEO
Nov 11, 2020 7:26am
Korro Bio hits the high notes with $91.5M series A
Sep 10, 2020 7:35am